Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
194.73
+4.74 (2.49%)
Jan 30, 2025, 4:00 PM EST - Market closed
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for INSP stock have an average target of 231.64, with a low estimate of 190 and a high estimate of 260. The average target predicts an increase of 18.95% from the current stock price of 194.73.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for INSP stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Maintains $200 → $190 | Hold | Maintains | $200 → $190 | -2.43% | Jan 21, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $220 → $255 | Hold → Strong Buy | Upgrades | $220 → $255 | +30.95% | Nov 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $260 | Buy | Reiterates | $260 | +33.52% | Nov 5, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $255 → $260 | Buy | Reiterates | $255 → $260 | +33.52% | Nov 5, 2024 |
| Stifel | Stifel | Hold Reiterates $170 → $200 | Hold | Reiterates | $170 → $200 | +2.71% | Nov 5, 2024 |
Financial Forecast
Revenue This Year
814.42M
from 624.80M
Increased by 30.35%
Revenue Next Year
968.53M
from 814.42M
Increased by 18.92%
EPS This Year
1.35
from -0.72
EPS Next Year
2.04
from 1.35
Increased by 50.66%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 842.9M | 1.0B | 1.2B | |||
| Avg | 814.4M | 968.5M | 1.1B | |||
| Low | 778.7M | 916.1M | 1.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 34.9% | 24.6% | 25.3% | |||
| Avg | 30.3% | 18.9% | 17.6% | |||
| Low | 24.6% | 12.5% | 9.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.47 | 2.72 | 4.96 | |||
| Avg | 1.35 | 2.04 | 3.24 | |||
| Low | 1.18 | 1.47 | 2.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 101.3% | 143.5% | |||
| Avg | - | 50.7% | 59.4% | |||
| Low | - | 8.8% | 11.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.